Informações:
Falhas:
ID
44073
Descrição
Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors; ODM derived from: https://clinicaltrials.gov/show/NCT00610389
Link
https://clinicaltrials.gov/show/NCT00610389
Palavras-chave
Versões (2)
- 28/09/2018 28/09/2018 -
- 20/09/2021 20/09/2021 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
20 de setembro de 2021
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Renal Cell Carcinoma NCT00610389
Eligibility Renal Cell Carcinoma NCT00610389
- StudyEvent: Eligibility
Similar models
Eligibility Renal Cell Carcinoma NCT00610389
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Metastatic melanoma | Renal Cell Carcinoma | Liver carcinoma Child-Pugh Classification | Curative treatment failed | Therapeutic procedure Post Hepatic embolisation allowed
Item
confirmed diagnosis of metastatic melanoma, renal cell carcinoma, or hepatocarcinoma (child´s stage a or b) not amenable of curative treatment. for patients with hepatocarcinoma, treatment after embolization is allowed
boolean
C0278883 (UMLS CUI [1])
C0007134 (UMLS CUI [2])
C2239176 (UMLS CUI [3,1])
C4050412 (UMLS CUI [3,2])
C1273390 (UMLS CUI [4,1])
C0231175 (UMLS CUI [4,2])
C0087111 (UMLS CUI [5,1])
C0687676 (UMLS CUI [5,2])
C0744813 (UMLS CUI [5,3])
C0683607 (UMLS CUI [5,4])
C0007134 (UMLS CUI [2])
C2239176 (UMLS CUI [3,1])
C4050412 (UMLS CUI [3,2])
C1273390 (UMLS CUI [4,1])
C0231175 (UMLS CUI [4,2])
C0087111 (UMLS CUI [5,1])
C0687676 (UMLS CUI [5,2])
C0744813 (UMLS CUI [5,3])
C0683607 (UMLS CUI [5,4])
Measurable Disease
Item
measurable disease
boolean
C1513041 (UMLS CUI [1])
ECOG performance status
Item
ecog 0, 1 or 2.
boolean
C1520224 (UMLS CUI [1])
Renal function | Liver function | Bone Marrow function
Item
adequate renal, hepatic and bone marrow function
boolean
C0232804 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0005953 (UMLS CUI [3,1])
C0031843 (UMLS CUI [3,2])
C0232741 (UMLS CUI [2])
C0005953 (UMLS CUI [3,1])
C0031843 (UMLS CUI [3,2])
Availability of Tumor tissue Dendritic Cells
Item
availability of tumor tissue, for maturing dendritic cells
boolean
C0470187 (UMLS CUI [1,1])
C0475358 (UMLS CUI [1,2])
C0011306 (UMLS CUI [1,3])
C0475358 (UMLS CUI [1,2])
C0011306 (UMLS CUI [1,3])
Disease Relevance Clinical | Communicable Diseases
Item
clinically relevant diseases or infections.
boolean
C0012634 (UMLS CUI [1,1])
C2347946 (UMLS CUI [1,2])
C0205210 (UMLS CUI [1,3])
C0009450 (UMLS CUI [2])
C2347946 (UMLS CUI [1,2])
C0205210 (UMLS CUI [1,3])
C0009450 (UMLS CUI [2])
Study Subject Participation Status | Cancer treatment
Item
concurrent participation in other clinical trial or administration or other antitumoral treatment
boolean
C2348568 (UMLS CUI [1])
C0920425 (UMLS CUI [2])
C0920425 (UMLS CUI [2])
Cancer Other
Item
concurrent cancer, with the exceptions allowed by the pi.
boolean
C1707251 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnant or breast feeding women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Therapeutic immunosuppression
Item
immunosuppressant treatment
boolean
C0021079 (UMLS CUI [1])
CNS metastases
Item
known cns metastasis
boolean
C0686377 (UMLS CUI [1])